Structure

Physi-Chem Properties

Molecular Weight:  330.22
Volume:  356.008
LogP:  4.911
LogD:  4.524
LogS:  -4.993
# Rotatable Bonds:  2
TPSA:  39.44
# H-Bond Aceptor:  3
# H-Bond Donor:  0
# Rings:  4
# Heavy Atoms:  3

MedChem Properties

QED Drug-Likeness Score:  0.673
Synthetic Accessibility Score:  4.512
Fsp3:  0.762
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Rejected
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.719
MDCK Permeability:  2.2752166842110455e-05
Pgp-inhibitor:  0.951
Pgp-substrate:  0.001
Human Intestinal Absorption (HIA):  0.002
20% Bioavailability (F20%):  0.387
30% Bioavailability (F30%):  0.962

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.065
Plasma Protein Binding (PPB):  95.18695068359375%
Volume Distribution (VD):  2.411
Pgp-substrate:  3.550715446472168%

ADMET: Metabolism

CYP1A2-inhibitor:  0.625
CYP1A2-substrate:  0.358
CYP2C19-inhibitor:  0.414
CYP2C19-substrate:  0.891
CYP2C9-inhibitor:  0.391
CYP2C9-substrate:  0.124
CYP2D6-inhibitor:  0.313
CYP2D6-substrate:  0.211
CYP3A4-inhibitor:  0.93
CYP3A4-substrate:  0.667

ADMET: Excretion

Clearance (CL):  6.811
Half-life (T1/2):  0.207

ADMET: Toxicity

hERG Blockers:  0.813
Human Hepatotoxicity (H-HT):  0.511
Drug-inuced Liver Injury (DILI):  0.858
AMES Toxicity:  0.011
Rat Oral Acute Toxicity:  0.23
Maximum Recommended Daily Dose:  0.149
Skin Sensitization:  0.636
Carcinogencity:  0.203
Eye Corrosion:  0.016
Eye Irritation:  0.055
Respiratory Toxicity:  0.974

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC307401

Natural Product ID:  NPC307401
Common Name*:   Deoxycaesaldekarin C
IUPAC Name:   [(4S,4aR,6aS,7R,11aS,11bR)-4,7,11b-trimethyl-1,2,3,4a,5,6,6a,7,11,11a-decahydronaphtho[2,1-f][1]benzofuran-4-yl] acetate
Synonyms:  
Standard InCHIKey:  YUAQBFTWNHXSHR-MEOKCCQFSA-N
Standard InCHI:  InChI=1S/C21H30O3/c1-13-15-6-7-19-20(3,9-5-10-21(19,4)24-14(2)22)17(15)12-18-16(13)8-11-23-18/h8,11,13,15,17,19H,5-7,9-10,12H2,1-4H3/t13-,15+,17+,19-,20-,21+/m1/s1
SMILES:  C[C@@H]1[C@@H]2CC[C@@H]3[C@](C)(CCC[C@]3(C)OC(=O)C)[C@H]2Cc2c1cco2
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL2381691
PubChem CID:   73354919
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000002] Organoheterocyclic compounds
      • [CHEMONTID:0001634] Naphthofurans

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO33322 caesalpinia volkensii Species Fabaceae Eukaryota stem bark n.a. n.a. PMID[23562058]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT6 Organism Plasmodium falciparum Plasmodium falciparum IC50 = 30330.0 nM PMID[548783]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum IC50 = 25670.0 nM PMID[548783]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC307401 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9697 High Similarity NPC202260
0.9231 High Similarity NPC59502
0.9197 High Similarity NPC263337
0.9143 High Similarity NPC71821
0.9137 High Similarity NPC290038
0.9098 High Similarity NPC293253
0.9085 High Similarity NPC228842
0.9085 High Similarity NPC212257
0.9071 High Similarity NPC233763
0.8992 High Similarity NPC178382
0.8915 High Similarity NPC16922
0.8881 High Similarity NPC95526
0.8865 High Similarity NPC56731
0.8855 High Similarity NPC74612
0.8828 High Similarity NPC294511
0.8828 High Similarity NPC121615
0.8819 High Similarity NPC472298
0.8797 High Similarity NPC198904
0.8779 High Similarity NPC179354
0.8777 High Similarity NPC56197
0.8776 High Similarity NPC104736
0.8776 High Similarity NPC41880
0.876 High Similarity NPC97566
0.8716 High Similarity NPC195954
0.8716 High Similarity NPC88007
0.8716 High Similarity NPC7059
0.8716 High Similarity NPC304692
0.8716 High Similarity NPC194499
0.8712 High Similarity NPC138139
0.8712 High Similarity NPC46536
0.8707 High Similarity NPC25351
0.8705 High Similarity NPC474722
0.8692 High Similarity NPC36255
0.8681 High Similarity NPC93666
0.8667 High Similarity NPC298190
0.8657 High Similarity NPC208389
0.8643 High Similarity NPC148374
0.8639 High Similarity NPC44606
0.8636 High Similarity NPC471074
0.8636 High Similarity NPC473885
0.86 High Similarity NPC8389
0.86 High Similarity NPC287559
0.8591 High Similarity NPC81405
0.8582 High Similarity NPC112706
0.8582 High Similarity NPC207294
0.8582 High Similarity NPC476917
0.8582 High Similarity NPC327527
0.8561 High Similarity NPC170604
0.8561 High Similarity NPC215109
0.8561 High Similarity NPC83115
0.8561 High Similarity NPC130275
0.8552 High Similarity NPC19747
0.8551 High Similarity NPC476947
0.8543 High Similarity NPC68848
0.8543 High Similarity NPC18986
0.8543 High Similarity NPC79571
0.8542 High Similarity NPC478166
0.8542 High Similarity NPC62799
0.8533 High Similarity NPC474611
0.8533 High Similarity NPC140952
0.8531 High Similarity NPC238843
0.8531 High Similarity NPC199044
0.8529 High Similarity NPC61788
0.8521 High Similarity NPC121158
0.8507 High Similarity NPC83178
0.8503 High Similarity NPC144010
0.85 High Similarity NPC476943
0.8496 Intermediate Similarity NPC230979
0.8493 Intermediate Similarity NPC211625
0.8489 Intermediate Similarity NPC46896
0.8487 Intermediate Similarity NPC285567
0.8487 Intermediate Similarity NPC475039
0.8487 Intermediate Similarity NPC283209
0.8487 Intermediate Similarity NPC476035
0.8487 Intermediate Similarity NPC14499
0.8483 Intermediate Similarity NPC224418
0.8483 Intermediate Similarity NPC216755
0.8472 Intermediate Similarity NPC114513
0.8472 Intermediate Similarity NPC245522
0.8467 Intermediate Similarity NPC473982
0.8462 Intermediate Similarity NPC470273
0.8456 Intermediate Similarity NPC476925
0.845 Intermediate Similarity NPC212918
0.8446 Intermediate Similarity NPC246164
0.8444 Intermediate Similarity NPC329707
0.8444 Intermediate Similarity NPC279877
0.844 Intermediate Similarity NPC233707
0.8429 Intermediate Similarity NPC42400
0.8421 Intermediate Similarity NPC188377
0.8421 Intermediate Similarity NPC188649
0.8421 Intermediate Similarity NPC471003
0.8421 Intermediate Similarity NPC65735
0.8421 Intermediate Similarity NPC118853
0.8417 Intermediate Similarity NPC324117
0.8417 Intermediate Similarity NPC209858
0.8414 Intermediate Similarity NPC471292
0.8411 Intermediate Similarity NPC123153
0.8406 Intermediate Similarity NPC218838
0.8406 Intermediate Similarity NPC470740
0.8403 Intermediate Similarity NPC251865
0.8403 Intermediate Similarity NPC84479
0.8394 Intermediate Similarity NPC89133
0.8389 Intermediate Similarity NPC10429
0.8385 Intermediate Similarity NPC87466
0.8385 Intermediate Similarity NPC243704
0.8377 Intermediate Similarity NPC277618
0.8377 Intermediate Similarity NPC121995
0.8372 Intermediate Similarity NPC59035
0.8372 Intermediate Similarity NPC79202
0.837 Intermediate Similarity NPC290955
0.837 Intermediate Similarity NPC246392
0.8369 Intermediate Similarity NPC236532
0.8366 Intermediate Similarity NPC88841
0.8366 Intermediate Similarity NPC288602
0.8358 Intermediate Similarity NPC290193
0.8357 Intermediate Similarity NPC214572
0.8357 Intermediate Similarity NPC146872
0.8356 Intermediate Similarity NPC471174
0.8356 Intermediate Similarity NPC281398
0.8355 Intermediate Similarity NPC472299
0.8333 Intermediate Similarity NPC205071
0.8312 Intermediate Similarity NPC276735
0.8312 Intermediate Similarity NPC56358
0.8311 Intermediate Similarity NPC477404
0.8311 Intermediate Similarity NPC196864
0.8309 Intermediate Similarity NPC477040
0.8309 Intermediate Similarity NPC26532
0.8298 Intermediate Similarity NPC470742
0.8298 Intermediate Similarity NPC310830
0.8298 Intermediate Similarity NPC310043
0.8296 Intermediate Similarity NPC23086
0.8295 Intermediate Similarity NPC150895
0.8289 Intermediate Similarity NPC472823
0.8288 Intermediate Similarity NPC262198
0.8286 Intermediate Similarity NPC158525
0.8276 Intermediate Similarity NPC476944
0.8273 Intermediate Similarity NPC471006
0.8269 Intermediate Similarity NPC296558
0.8267 Intermediate Similarity NPC471863
0.8267 Intermediate Similarity NPC114880
0.8264 Intermediate Similarity NPC52412
0.8252 Intermediate Similarity NPC476191
0.8252 Intermediate Similarity NPC67003
0.8248 Intermediate Similarity NPC120836
0.8248 Intermediate Similarity NPC223063
0.8243 Intermediate Similarity NPC234494
0.8243 Intermediate Similarity NPC471001
0.8239 Intermediate Similarity NPC177262
0.8239 Intermediate Similarity NPC220094
0.8231 Intermediate Similarity NPC286038
0.8231 Intermediate Similarity NPC255414
0.8231 Intermediate Similarity NPC221809
0.8222 Intermediate Similarity NPC300098
0.8217 Intermediate Similarity NPC302392
0.8217 Intermediate Similarity NPC88593
0.8209 Intermediate Similarity NPC272899
0.8207 Intermediate Similarity NPC243577
0.8205 Intermediate Similarity NPC473766
0.8205 Intermediate Similarity NPC41689
0.8205 Intermediate Similarity NPC473753
0.8205 Intermediate Similarity NPC270312
0.8201 Intermediate Similarity NPC164295
0.8201 Intermediate Similarity NPC196979
0.8201 Intermediate Similarity NPC470976
0.8201 Intermediate Similarity NPC470977
0.8201 Intermediate Similarity NPC471817
0.8194 Intermediate Similarity NPC126984
0.8194 Intermediate Similarity NPC27541
0.8194 Intermediate Similarity NPC62692
0.8194 Intermediate Similarity NPC61967
0.8188 Intermediate Similarity NPC469335
0.8188 Intermediate Similarity NPC470997
0.8188 Intermediate Similarity NPC159927
0.8188 Intermediate Similarity NPC476122
0.8188 Intermediate Similarity NPC156189
0.8176 Intermediate Similarity NPC66991
0.8175 Intermediate Similarity NPC477966
0.8175 Intermediate Similarity NPC477123
0.817 Intermediate Similarity NPC473368
0.817 Intermediate Similarity NPC84349
0.8168 Intermediate Similarity NPC227660
0.8163 Intermediate Similarity NPC346
0.8158 Intermediate Similarity NPC107646
0.8156 Intermediate Similarity NPC92941
0.8154 Intermediate Similarity NPC205523
0.8151 Intermediate Similarity NPC142113
0.8148 Intermediate Similarity NPC243269
0.8141 Intermediate Similarity NPC308156
0.8133 Intermediate Similarity NPC272590
0.8129 Intermediate Similarity NPC282230
0.8129 Intermediate Similarity NPC183348
0.8121 Intermediate Similarity NPC470790
0.8121 Intermediate Similarity NPC470791
0.8121 Intermediate Similarity NPC69647
0.8121 Intermediate Similarity NPC125182
0.8121 Intermediate Similarity NPC192069
0.8108 Intermediate Similarity NPC470941
0.8095 Intermediate Similarity NPC27798
0.8095 Intermediate Similarity NPC185456
0.8095 Intermediate Similarity NPC93241

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC307401 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.831 Intermediate Similarity NPD2343 Clinical (unspecified phase)
0.8231 Intermediate Similarity NPD6273 Approved
0.8201 Intermediate Similarity NPD8032 Phase 2
0.7922 Intermediate Similarity NPD5616 Clinical (unspecified phase)
0.7891 Intermediate Similarity NPD7003 Approved
0.781 Intermediate Similarity NPD3972 Approved
0.7808 Intermediate Similarity NPD1471 Phase 3
0.7793 Intermediate Similarity NPD2799 Discontinued
0.7791 Intermediate Similarity NPD6764 Approved
0.7791 Intermediate Similarity NPD6765 Approved
0.7742 Intermediate Similarity NPD5761 Phase 2
0.7742 Intermediate Similarity NPD5760 Phase 2
0.7703 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7698 Intermediate Similarity NPD1876 Approved
0.7687 Intermediate Similarity NPD2346 Discontinued
0.7665 Intermediate Similarity NPD8434 Phase 2
0.7651 Intermediate Similarity NPD4628 Phase 3
0.7647 Intermediate Similarity NPD5585 Approved
0.7639 Intermediate Similarity NPD4140 Approved
0.7639 Intermediate Similarity NPD4307 Phase 2
0.7609 Intermediate Similarity NPD1281 Approved
0.7609 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.7606 Intermediate Similarity NPD6832 Phase 2
0.7605 Intermediate Similarity NPD6784 Approved
0.7605 Intermediate Similarity NPD6785 Approved
0.7597 Intermediate Similarity NPD7458 Discontinued
0.7597 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7594 Intermediate Similarity NPD1241 Discontinued
0.7591 Intermediate Similarity NPD3412 Clinical (unspecified phase)
0.7589 Intermediate Similarity NPD2798 Approved
0.7551 Intermediate Similarity NPD3748 Approved
0.755 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7547 Intermediate Similarity NPD5537 Clinical (unspecified phase)
0.7518 Intermediate Similarity NPD5691 Approved
0.7518 Intermediate Similarity NPD2797 Approved
0.7518 Intermediate Similarity NPD3267 Approved
0.7518 Intermediate Similarity NPD3266 Approved
0.7517 Intermediate Similarity NPD2979 Phase 3
0.75 Intermediate Similarity NPD2313 Discontinued
0.75 Intermediate Similarity NPD5327 Phase 3
0.7468 Intermediate Similarity NPD920 Approved
0.7464 Intermediate Similarity NPD17 Approved
0.7451 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.745 Intermediate Similarity NPD2344 Approved
0.7447 Intermediate Similarity NPD1283 Approved
0.7432 Intermediate Similarity NPD4308 Phase 3
0.7431 Intermediate Similarity NPD5952 Clinical (unspecified phase)
0.7417 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7405 Intermediate Similarity NPD7819 Suspended
0.7391 Intermediate Similarity NPD1651 Approved
0.7383 Intermediate Similarity NPD2796 Approved
0.7379 Intermediate Similarity NPD3268 Approved
0.7379 Intermediate Similarity NPD3764 Approved
0.7376 Intermediate Similarity NPD4359 Approved
0.7372 Intermediate Similarity NPD3226 Approved
0.7368 Intermediate Similarity NPD2181 Clinical (unspecified phase)
0.7351 Intermediate Similarity NPD1243 Approved
0.7347 Intermediate Similarity NPD6355 Discontinued
0.7347 Intermediate Similarity NPD1899 Clinical (unspecified phase)
0.7346 Intermediate Similarity NPD8127 Discontinued
0.7338 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7325 Intermediate Similarity NPD6599 Discontinued
0.732 Intermediate Similarity NPD7236 Approved
0.731 Intermediate Similarity NPD7095 Approved
0.7305 Intermediate Similarity NPD1608 Approved
0.7303 Intermediate Similarity NPD4110 Phase 3
0.7303 Intermediate Similarity NPD4109 Clinical (unspecified phase)
0.7303 Intermediate Similarity NPD3750 Approved
0.7303 Intermediate Similarity NPD8166 Discontinued
0.7267 Intermediate Similarity NPD3749 Approved
0.7267 Intermediate Similarity NPD2531 Phase 2
0.7267 Intermediate Similarity NPD2438 Suspended
0.7267 Intermediate Similarity NPD4477 Approved
0.7267 Intermediate Similarity NPD2935 Discontinued
0.7267 Intermediate Similarity NPD4476 Approved
0.726 Intermediate Similarity NPD6798 Discontinued
0.7259 Intermediate Similarity NPD5535 Approved
0.7255 Intermediate Similarity NPD2309 Approved
0.7255 Intermediate Similarity NPD3887 Approved
0.723 Intermediate Similarity NPD4622 Approved
0.723 Intermediate Similarity NPD4618 Approved
0.7222 Intermediate Similarity NPD919 Approved
0.7214 Intermediate Similarity NPD4626 Approved
0.7214 Intermediate Similarity NPD1778 Approved
0.7211 Intermediate Similarity NPD6663 Approved
0.7197 Intermediate Similarity NPD3134 Approved
0.7172 Intermediate Similarity NPD5736 Approved
0.717 Intermediate Similarity NPD7411 Suspended
0.7163 Intermediate Similarity NPD7457 Clinical (unspecified phase)
0.716 Intermediate Similarity NPD6559 Discontinued
0.7152 Intermediate Similarity NPD6100 Approved
0.7152 Intermediate Similarity NPD6099 Approved
0.7152 Intermediate Similarity NPD1551 Phase 2
0.7143 Intermediate Similarity NPD3024 Approved
0.7143 Intermediate Similarity NPD3025 Approved
0.7134 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7133 Intermediate Similarity NPD5688 Approved
0.7133 Intermediate Similarity NPD5689 Approved
0.7126 Intermediate Similarity NPD7893 Clinical (unspecified phase)
0.7125 Intermediate Similarity NPD6279 Approved
0.7125 Intermediate Similarity NPD6280 Approved
0.7114 Intermediate Similarity NPD1933 Approved
0.7107 Intermediate Similarity NPD7028 Phase 2
0.7105 Intermediate Similarity NPD2353 Approved
0.7105 Intermediate Similarity NPD2355 Clinical (unspecified phase)
0.7103 Intermediate Similarity NPD1019 Discontinued
0.7099 Intermediate Similarity NPD7768 Phase 2
0.7095 Intermediate Similarity NPD4870 Approved
0.7092 Intermediate Similarity NPD3019 Approved
0.7091 Intermediate Similarity NPD6808 Phase 2
0.7089 Intermediate Similarity NPD7239 Suspended
0.7081 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7075 Intermediate Similarity NPD7008 Discontinued
0.7073 Intermediate Similarity NPD5494 Approved
0.7071 Intermediate Similarity NPD1894 Discontinued
0.7067 Intermediate Similarity NPD6353 Approved
0.7063 Intermediate Similarity NPD9717 Approved
0.7059 Intermediate Similarity NPD1609 Clinical (unspecified phase)
0.7059 Intermediate Similarity NPD2897 Discontinued
0.7051 Intermediate Similarity NPD6799 Approved
0.7047 Intermediate Similarity NPD3142 Approved
0.7047 Intermediate Similarity NPD4060 Phase 1
0.7047 Intermediate Similarity NPD3140 Approved
0.7042 Intermediate Similarity NPD3496 Discontinued
0.7042 Intermediate Similarity NPD3023 Approved
0.7042 Intermediate Similarity NPD3026 Approved
0.7034 Intermediate Similarity NPD1049 Clinical (unspecified phase)
0.7034 Intermediate Similarity NPD1203 Approved
0.7029 Intermediate Similarity NPD5951 Approved
0.7025 Intermediate Similarity NPD3869 Phase 3
0.7025 Intermediate Similarity NPD7427 Discontinued
0.7025 Intermediate Similarity NPD3873 Phase 3
0.702 Intermediate Similarity NPD7097 Phase 1
0.7 Intermediate Similarity NPD5735 Approved
0.6993 Remote Similarity NPD6287 Discontinued
0.6993 Remote Similarity NPD1611 Approved
0.6987 Remote Similarity NPD7440 Discontinued
0.6986 Remote Similarity NPD4624 Approved
0.6982 Remote Similarity NPD5844 Phase 1
0.698 Remote Similarity NPD6233 Phase 2
0.6972 Remote Similarity NPD2932 Approved
0.6963 Remote Similarity NPD2182 Approved
0.6962 Remote Similarity NPD5049 Phase 3
0.6957 Remote Similarity NPD6873 Phase 2
0.6951 Remote Similarity NPD7075 Discontinued
0.6948 Remote Similarity NPD4534 Discontinued
0.6943 Remote Similarity NPD6143 Clinical (unspecified phase)
0.6933 Remote Similarity NPD8443 Clinical (unspecified phase)
0.6923 Remote Similarity NPD7177 Discontinued
0.6923 Remote Similarity NPD2354 Approved
0.6914 Remote Similarity NPD7577 Discontinued
0.6914 Remote Similarity NPD6801 Discontinued
0.6913 Remote Similarity NPD6859 Clinical (unspecified phase)
0.6913 Remote Similarity NPD411 Approved
0.6905 Remote Similarity NPD7852 Clinical (unspecified phase)
0.6899 Remote Similarity NPD2532 Approved
0.6899 Remote Similarity NPD2534 Approved
0.6899 Remote Similarity NPD7410 Clinical (unspecified phase)
0.6899 Remote Similarity NPD4378 Clinical (unspecified phase)
0.6899 Remote Similarity NPD2533 Approved
0.6892 Remote Similarity NPD2614 Approved
0.689 Remote Similarity NPD4947 Clinical (unspecified phase)
0.6889 Remote Similarity NPD1358 Approved
0.6884 Remote Similarity NPD6858 Approved
0.6884 Remote Similarity NPD7094 Approved
0.6883 Remote Similarity NPD6005 Phase 3
0.6883 Remote Similarity NPD6002 Phase 3
0.6883 Remote Similarity NPD5762 Approved
0.6883 Remote Similarity NPD6003 Clinical (unspecified phase)
0.6883 Remote Similarity NPD6004 Phase 3
0.6883 Remote Similarity NPD6006 Clinical (unspecified phase)
0.6883 Remote Similarity NPD5763 Approved
0.687 Remote Similarity NPD1238 Approved
0.6866 Remote Similarity NPD9697 Approved
0.6863 Remote Similarity NPD7033 Discontinued
0.6852 Remote Similarity NPD6677 Suspended
0.6852 Remote Similarity NPD5889 Approved
0.6852 Remote Similarity NPD5890 Approved
0.6839 Remote Similarity NPD970 Clinical (unspecified phase)
0.6839 Remote Similarity NPD5958 Discontinued
0.6839 Remote Similarity NPD1549 Phase 2
0.6832 Remote Similarity NPD2649 Approved
0.6832 Remote Similarity NPD2651 Approved
0.6831 Remote Similarity NPD9545 Approved
0.6829 Remote Similarity NPD3817 Phase 2
0.6826 Remote Similarity NPD1247 Approved
0.6813 Remote Similarity NPD4107 Approved
0.6813 Remote Similarity NPD5403 Approved
0.681 Remote Similarity NPD37 Approved
0.68 Remote Similarity NPD8055 Clinical (unspecified phase)
0.6792 Remote Similarity NPD5401 Approved
0.679 Remote Similarity NPD6585 Discontinued
0.6788 Remote Similarity NPD4868 Clinical (unspecified phase)
0.6788 Remote Similarity NPD4965 Approved
0.6788 Remote Similarity NPD7057 Phase 3
0.6788 Remote Similarity NPD7058 Phase 2
0.6788 Remote Similarity NPD4967 Phase 2
0.6788 Remote Similarity NPD4966 Approved
0.6786 Remote Similarity NPD7229 Phase 3
0.6782 Remote Similarity NPD8313 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data